METHODS:
This was a single-site, retrospective descriptive study that included data from breast reconstruction procedures from April 2014 -Apr 2016. Data extracted included patient-related variables such as demographics, chemotherapy and radiation exposure, surgery-related variables such as immediate or delayed reconstruction, one vs. two stage and patient outcomes such as post-operative complications and length of stay. Patients with a follow up time of less than 90 days were excluded from this dataset. Means and standard deviations were computed for continuous variables and counts and proportions were calculated for categorical variables. Patient characteristics and length of stay were summarized at the patient-level whereas complication rates were summarized at the breast-level.
RESULTS:
The dataset included data on 142 patients (n=236 breasts). The mean age for these patients was 51.5 ± 10.9 years and BMI was 27.4 ± 5.3 kg/m 2 . Forty patients (28.2%) were obese and over 98% patients were undergoing primary breast reconstruction. The majority of patients in this dataset received immediate breast reconstruction (96.5%). Twenty-seven patients (19%) had radiation exposure whereas 54 patients (36.8%) had chemotherapy exposure either before or after reconstruction. ADM was used for reinforcement in all reconstructions. The mean follow up time was 1.1 ± 0.5 years. Complication rates were as follows: surgical site infection (6.8%), dehiscence (3.4%), necrosis (10.6%), seroma (13.6%), hematoma (0.4%), tissue expander exposure (0.8%). The mean length of stay for patients was 1.6 ± 0.5 days.
CONCLUSION:
This preliminary data analysis demonstrated low complication rates using the pre-pectoral breast reconstruction technique. Additional studies comparing pre-pectoral technique to sub-pectoral technique are warranted to further understand the impact of surgical techniques on patient outcomes. 
Delay Techniques in

INTRODUCTION:
Nipple-sparing mastectomy (NSM) has become a popular method of oncologic breast surgery, allowing for more natural-appearing reconstructed breasts compared to traditional mastectomy. Ischemic complications of skin flaps and the nipple-areola complex (NAC) can lead to prosthetic explantation and need for revision. Several papers have been published describing delay techniques in patients planned to undergo NSM. Our goal is to demonstrate outcomes in our patient population who underwent a delay procedure prior to NSM.
METHODS:
We conducted an IRB-approved retrospective review of patients who underwent a www.PRSGlobalOpen.com delay procedure. The first stage involved undermining the NAC and mastectomy skin flap. At this time, a retroareolar biopsy was performed and, in some cases, a sentinel lymph node biopsy. Subsequently, patients underwent nipple-sparing mastectomy. Patient data including age, comorbidities, breast scars, smoking, delay characteristics, and any complications were recorded.
RESULTS:
Forty-seven patients (88 breasts) were included in the study. The average age was 48 (range: 30-64). Forty-three patients had confirmed breast cancer diagnosis, 4 patients were BRCA positive. Thirty-one patients underwent a delay, average time between delay and NSM was 15 days. One patient had a positive retroareolar biopsy and underwent traditional mastectomy. Two patients had areas of nipple necrosis that resolved without reoperation, four cases of skin necrosis required re-operation. In these patients, three had previous breast surgery and one patient was a smoker.
CONCLUSION/SIGNIFICANCE:
A two-stage approach to NSM can reduce risk of skin and NAC necrosis, while allowing for retroareolar and sentinel lymph node biopsies to be performed. This is especially important for high-risk patients. . This 4-fold difference is replicated in other national studies and appears not to be determined by patients' underlying oncology, but by multi-disciplinary network access variables. Ambulatory care (same-day discharge) has become normative for the majority of index breast procedures, driven by convenience, cost benefit, 2 improved efficiencies and the aggregation of evolved techniques such as anatomical flap dissection, dual probe sentinel node staging, multimodal pain management, surgical site infection control bundles, integrated discharge planning 3 and validated outcome datasets. 4 This report aims to demonstrate proof of principle, by utilising ambulatory care protocols to leverage IBR access. We systematically review the evidence for ambulatory immediate breast reconstruction to date; and report on a single unit's clinical experience over six months (April -September 2016) .
Elective, Outpatients Immediate Breast
METHODS:
A systematic (PRISMA) review was undertaken in January 2017. Search keywords included 'breast reconstruction', 'mammaplasty', 'ambulatory surgery' and 'enhanced recovery after surgery'. We queried Medline (Ovid), Embase, NHS IC audits for clinical studies (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) with no language or sample-size restrictions.
Our IBR practice includes: 24-hour discharge monitoring by nurse-led practitioners; Novel, ambulatory IBR was grafted onto the existing pathway in discussion with suitable patients. We describe the cohorts' demographics oncology dataset, perioperative times and outcomes.
RESULTS:
There are no reported studies evaluating ambulatory, immediate breast reconstruction. Between April and September 2016, three patients underwent ambulatory implant-based IBR. They were selected 'organically' with normative peri-operative screening and outcomes. They all underwent skin sparing mastectomies with implant/ADM (Surgimend PRS) IBR: mean operative time of 2 hours, 35mins; mean time to discharge 4 hours and 27mins; and 6 months follow-up with no unplanned readmissions and a normative postoperative recovery pathway.
CONCLUSION:
There is no reported evidence for ambulatory IBR we are aware of. Utilising our existing ambulatory care pathway, outpatient elective IBR is feasible. A prospective outcomes study 5 with validated patient reported instruments would be a way to offer enhanced access to IBR in suitable patients.
